Trifecta主动脉瓣膜可降低患者-人工瓣膜不匹配发生率
本研究纳入1302例术后3个月患者,比较Trifecta瓣膜(339例)与Mitroflow瓣膜(963例)的患者-人工瓣膜不匹配发生率。结果显示Trifecta组任何程度不匹配为5.9%,Mitroflow组为42.4%,差异显著(p<0.001)。Trifecta瓣膜对中度和重度不匹配的比值比分别为16.9和11.9。
要点
- Trifecta瓣膜术后3个月任何程度不匹配发生率仅5.9%。
- Mitroflow瓣膜组不匹配发生率高达42.4%。
- Trifecta瓣膜对中度和重度不匹配均显示保护作用。
核心结论
- 使用Trifecta主动脉瓣膜的患者-人工瓣膜不匹配发生率极低。
研究设计与样本
- 研究纳入1302例术后3个月患者,其中Trifecta组339例,Mitroflow对照组963例。
- 采用多项多变量逻辑回归评估Trifecta瓣膜与中重度不匹配的关联。
主要发现
- 任何程度不匹配:Trifecta组5.9%,Mitroflow组42.4%。
- 中度不匹配:Trifecta组3.8%,Mitroflow组32.6%。
- 重度不匹配:Trifecta组2.1%,Mitroflow组9.8%。
- 所有差异均具有统计学显著性(p < 0.001)。
- Trifecta瓣膜防止不匹配的比值比:中度16.9(95%CI 9.5-30.4),重度11.9(95%CI 5.3-26.7)。
临床怎么用
- 在主动脉瓣置换术中,选用Trifecta瓣膜可能有助于降低患者-人工瓣膜不匹配的风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Some important studies have shown that patient-prosthesis mismatch is a frequent occurrence after surgical aortic valve replacement that impairs survival. The Trifecta valve (St. Jude Medical Inc, St. Paul, MN) has special architecture designed to achieve the best hemodynamic profile. The aim of this study was to determine the prevalence of mismatch when using this prosthesis. METHODS: This study included 1,302 patients at 3 months postoperatively, 339 patients with a Trifecta prosthesis and 963 patients (the control group) with a Mitroflow aortic valve (Sorin Group Inc, Mitroflow Division, Vancouver, Canada). Multinomial multivariate logistic regression was calculated to estimate the association between the Trifecta prosthesis and moderate or severe patient-prosthesis mismatch. RESULTS: Any degree of mismatch was present in 5.9% of the Trifecta group and in 42.4% in the Mitroflow group. Moderate patient-prosthesis mismatch was present in 3.8% of the patients with a Trifecta valve and in 32.6% in the Mitroflow group. Severe mismatch was present in 2.1% of the patients with a Trifecta prosthesis and in 9.8% of the patients with a Mitroflow valve. All differences were statistically significant (p < 0.001). The odds ratio of the Trifecta prosthesis as protector against mismatch was 16.9 (95% confidence interval, 9.5 to 30.4) and 11.9 (95% confidence interval, 5.3 to 26.7) for moderate or severe mismatch, respectively. CONCLUSIONS: The prevalence of patient-prosthesis mismatch using the Trifecta aortic prosthesis is extraordinary low. This finding may have great clinical repercussions in patients undergoing surgical aortic valve replacement.
引用
- Hernandez-Vaquero D, Diaz R, Pascual I, et al. The Prevalence of Patient-Prosthesis Mismatch Can Be Reduced Using the Trifecta Aortic Prosthesis. Ann Thorac Surg. 2017. PMID: 28964416. doi:10.1016/j.athoracsur.2017.05.076
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。